Related Experiment Video
Updated: May 12, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
[Interstitial lung disease in polymyositis/dermatomyositis]
1Klinik für Rheumatologie und Innere Medizin, Sana Gelenk- und Rheumazentrum Baden-Württemberg, König-Karl-Str. 5, 75323 Bad Wildbad, Deutschland. armin.schnabel@sana.de
Zeitschrift Fur Rheumatologie
|April 5, 2013
Summary
Interstitial lung disease (ILD) affects 40% of polymyositis/dermatomyositis (PM/DM) patients, often presenting as non-specific interstitial pneumonia. Early diagnosis via autoantibody testing, spirometry, and HRCT is crucial for managing this inflammatory lung condition.
Area of Science:
- Rheumatology
- Pulmonology
- Immunology
Context:
- 40% of polymyositis/dermatomyositis (PM/DM) patients exhibit interstitial lung disease (ILD).
- Non-specific interstitial pneumonia is the most common histopathological type, featuring significant inflammation.
- Early detection is key for managing PM/DM-associated ILD.
Purpose:
- To outline the diagnostic utility of clinical, HRCT, and BAL findings in early ILD stages.
- To provide an overview of current therapeutic strategies for ILD in PM/DM patients.
- To discuss the prognostic value of diagnostic findings in ILD.
Summary:
- Comprehensive screening reveals ILD in 40% of PM/DM patients, predominantly as non-specific interstitial pneumonia.
- Diagnostic tools include autoantibody testing, spirometry (CO diffusion capacity), and high-resolution computed tomography (HRCT).
- Clinical, HRCT, and bronchoalveolar lavage (BAL) findings aid in prognostication and treatment selection.
Impact:
- Facilitates earlier diagnosis and intervention for ILD in PM/DM.
- Improves prognostic assessment through integrated diagnostic findings.
- Informs current treatment options for better patient outcomes in PM/DM-associated ILD.
Related Concept Videos
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
01:27Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...